AbbVie's Life After Abbott – Motley Fool
AbbVie's Life After AbbottMotley FoolOne of the drugs the company pins future hopes on is daclizumab, which is used to treat relapsing multiple sclerosis. A phase 3 clinical trial is currently under way for the drug in collaboration with Biogen (NA…
